Although quantifying protein expression in the leptin signaling pathway in the brain would be a relevant approach to directly confirm these influences, our findings suggest that improvements in the A/L ratio, reduction of TNF-α levels, and decreased visceral fat deposition may be associated with restored leptin sensitivity, contributing to metabolic and inflammatory regulation in obesity. The gene discussed is LEP; the disease is obesity disorder.